Risks of myeloid malignancies in patients with autoimmune conditions

British Journal of Cancer

Volumn 100, Issue 5, 2009, Pages 822-828

  Anderson, L A ^a   Pfeiffer, R M ^b   Landgren, O ^b   Gadalla, S ^b   Berndt, S I ^b   Engels, E A ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autoimmune conditions; Chronic myeloproliferative diseases; Myelodysplastic syndrome; Myeloid leukaemia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC PREDISPOSITION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; OVERALL SURVIVAL; PERNICIOUS ANEMIA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; ULCERATIVE COLITIS; UNITED STATES;

AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; FEMALE; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; MYELODYSPLASTIC-MYELOPROLIFERATIVE DISEASES; MYELOPROLIFERATIVE DISORDERS; ODDS RATIO; RISK FACTORS; TIME FACTORS;

EID: 61749100610     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604935     Document Type: Article

References (35)

1. Alexson E, Brandt KD (1977) Acute leukemia after azathioprine treatment of connective tissue disease. Am J Med Sci 273: 335-340
2. Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA (2008) Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 17: 3069-3075
3. Anton E (2007) More on polymyalgia rheumatica (PMR) as a paraneoplastic rheumatic syndrome in the elderly (bicytopenia and PMR preceding acute myeloid leukemia). J Clin Rheumatol 13: 114
4. Arbaje YM, Beltran G (1990) Chronic myelogenous leukemia complicated by autoimmune hemolytic anemia. Am J Med 88: 197-199
5. Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, Ekbom A (2005a) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54: 617-622
6. Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundstrom C, Bertilsson L, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Saxne T, Klareskog L, Feltelius N (2005b) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64: 1414-1420
7. Au WY, Hawkins BR, Cheng N, Lie AK, Liang R, Kwong YL (2001) Risk of haematological malignancies in HLA-B27 carriers. Br J Haematol 115: 320-322
8. Bernstein CN, Blanchard JF, Kliewer E, Wajda A (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91: 854-862
9. Dalamaga M, Petridou E, Cook FE, Trichopoulos D (2002) Risk factors for myelodysplastic syndromes: a case-control study in Greece. Cancer Causes Control 13: 603-608
10. Demeter J, Messer G, Ramisch S, Mee JB, di Giovine FS, Schmid M, Herrmann F, Porzsolt F (1996) Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokines Mol Ther 2: 239-242
11. Descatha A, Jenabian A, Conso F, Ameille J (2005) Occupational exposures and haematological malignancies: overview on human recent data. Cancer Causes Control 16: 939-953
12. Deutsch M, Dourakis SP, Papanikolopoulos K, Belegrati M, Kalmantis T (2003) Autoimmune hemolytic anemia in a patient with acute myelocytic leukemia. Am J Hematol 74: 147
13. Ekstrom Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjose S, Chiu BC, Dal Maso L, Cocco P, Maynadie M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111: 4029-4038
14. Espinosa G, Font J, Munoz-Rodriguez FJ, Cervera R, Ingelmo M (2002) Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol 21: 309-313
15. Giagounidis AA, Haase S, Germing U, Heinsch M, Aul C (2005) Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion. Acta Haematol 113: 146-149
16. Hemminki K, Li X, Sundquist J, Sundquist K (2008) Cancer risks in ulcerative colitis patients. Int J Cancer 123: 1417-1421
17. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, Fraumeni JF (1993) Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 71: 745-750
18. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. IARC: Lyon
19. Kasim K, Levallois P, Abdous B, Auger P, Johnson KC (2005) Lifestyle factors and the risk of adult leukemia in Canada. Cancer Causes Control 16: 489-500
20. Kwong YL, Au WY, Liang RH (1998) Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: association with -7/7q-. Cancer Genet Cytogenet 104: 94-97
21. Mok CC, Lau CS, Kumana CR (1996) Polymyalgia rheumatica as the rheumatological manifestation of myelodysplastic syndrome in a Chinese patient. Br J Rheumatol 35: 496-497
22. Nisse C, Haguenoer JM, Grandbastien B, Preudhomme C, Fontaine B, Brillet JM, Lejeune R, Fenaux P (2001) Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 112: 927-935
23. Okamoto H, Teramura M, Kamatani N (2004) Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis. Ann Pharmacother 38: 172-173
24. Pogoda JM, Katz J, McKean-Cowdin R, Nichols PW, Ross RK, Preston-Martin S (2005) Prescription drug use and risk of acute myeloid leukemia by French-American-British subtype: results from a Los Angeles County case-control study. Int J Cancer 114: 634-638
25. Preston-Martin S, Thomas DC, Yu MC, Henderson BE (1989) Diagnostic radiography as a risk factor for chronic myeloid and monocytic leukaemia (CML). Br J Cancer 59: 639-644
26. Soderberg KC, Jonsson F, Winqvist O, Hagmar L, Feychting M (2006) Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. Eur J Cancer 42(17): 3028-3033
27. Steurer M, Fritsche G, Tzankov A, Gotwald T, Sturm W, Konwalinka G, Gruber J (2004) Large-vessel arteritis and myelodysplastic syndrome: report of two cases. Eur J Haematol 73: 128-133
28. Stockton D, Doherty VR, Brewster DH (2001) Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85: 41-45
29. Strom SS, Gu Y, Gruschkus SK, Pierce SA, Estey EH (2005) Risk factors of myelodysplastic syndromes: a case-control study. Leukemia 19: 1912-1918
30. Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG (2004) Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 34: 690-700
31. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40: IV-3-IV-18
32. Winther KV, Jess T, Langholz E, Munkholm P, Binder V (2004) Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2: 1088-1095
33. Xu X, Talbott EO, Zborowski JV, Rager JR (2007) Cigarette smoking and the risk of adult leukemia: results from the Three Mile Island cohort study. Arch Environ Occup Health 62: 131-137
34. Zheng W, Linet MS, Shu XO, Pan RP, Gao YT, Fraumeni Jr JF (1993) Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China. Cancer Causes Control 4: 361-368
35. Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165: 2337-2344